Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Pistol shooter Divanshi bagged a second individual gold in the women’s 25m standard pist
- Paralympics: BAI announces Rs 50 lakh cash reward for medallist para-shuttlers
- Laver Cup: Tiafoe upsets Medvedev, Alcaraz pulls Team Europe level with Team World
- Cincinnati Open: Tiafoe, Hurkacz, Rune and Draper in the quarters
- Paris Olympics: Abhinav Bindra 'completely gutted' after Vinesh Phogat's disqualification
- Paris Olympics: USA, China in Top-2, India slip to 60th
Pfizer says its booster restores full protection against Covid Last Updated : 22 Oct 2021 10:05:58 AM IST Pfizer and BioNTech has announced that a large-scale trial of their Covid-19 vaccine booster showed it restored full protection against the disease.
In a Phase 3 randomised, controlled trial, a Pfizer-BioNTech booster dose was administered to more than 10,000 individuals 16 years of age and older, who previously received the Pfizer-BioNTech primary two-dose series, reports Xinhua news agency.It showed a relative vaccine efficacy of 95.6 per cent when compared to those who did not receive a booster.These are the first efficacy results from any randomized, controlled Covid-19 vaccine booster trial."These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease," said Albert Bourla, Pfizer Chairman and Chief Executive Officer.Last month, the Food and Drug Administration authorised the booster shots for the Pfizer-BioNTech Covid-19 vaccine, allowing a single booster dose of the Pfizer-BioNTech vaccine be administered at least six months after completion of the primary series to individuals 65 years of age and older, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2.IANS Washington For Latest Updates Please-
Join us on
Follow us on
172.31.16.186